切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2019, Vol. 13 ›› Issue (03) : 202 -207. doi: 10.3877/cma.j.issn.1674-1358.2019.03.006

所属专题: 文献

论著

慢性阻塞性肺疾病合并肺部感染者病原菌分布及相关血清细胞因子水平对临床转归的影响
范莎1,(), 郭磊1   
  1. 1. 046000 长治市,长治医学院附属和济医院呼吸内科
  • 收稿日期:2018-11-01 出版日期:2019-06-15
  • 通信作者: 范莎

Effects of pathogenic bacteria distribution and serum cytokine levels on clinical outcomes of patients with chronic obstructive pulmonary disease complicated with pulmonary infection

Sha Fan1,(), Lei Guo1   

  1. 1. Department of Respiratory Medicine, Heji Hospital Affiliated to Changzhi Medical College, Changzhi 046000, China
  • Received:2018-11-01 Published:2019-06-15
  • Corresponding author: Sha Fan
  • About author:
    Corresponding author: Fan Sha, Email:
引用本文:

范莎, 郭磊. 慢性阻塞性肺疾病合并肺部感染者病原菌分布及相关血清细胞因子水平对临床转归的影响[J/OL]. 中华实验和临床感染病杂志(电子版), 2019, 13(03): 202-207.

Sha Fan, Lei Guo. Effects of pathogenic bacteria distribution and serum cytokine levels on clinical outcomes of patients with chronic obstructive pulmonary disease complicated with pulmonary infection[J/OL]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2019, 13(03): 202-207.

目的

分析慢性阻塞性肺疾病(COPD)合并肺部感染者病原菌分布以及相关血清细胞因子水平对患者临床转归的影响。

方法

选取2015年2月至2017年2月长治医学院附属和济医院收治的178例COPD合并肺部感染者作为研究对象;采用呼吸道9项病毒荧光标记PCR进行病毒鉴定;采用BD BACTEC? FX40全自动细菌鉴定仪鉴定细菌种类;采用酶联免疫吸附法(ELISA)检测血清白细胞介素(IL-6、IL-10)、干扰素(IFN-α、IFN-γ)和肿瘤坏死因子(TNF-α、TNF-β)水平;并分析以上指标对COPD合并肺部感染者临床转归的影响。

结果

178例入组患者根据感染病原体不同分为病毒感染组36例(20.22%)和细菌感染组(142例),其中细菌感染组患者中革兰阳性菌感染者47例(26.41%),革兰阴性菌感染者95例(53.37%)。细菌感染组患者血清IL-6、IL-10、IFN-α、IFN-γ、TNF-α和TNF-β水平均显著高于病毒感染组,差异均有统计学意义(P均< 0.001)。178例患者中住院天数≥ 7 d者和死亡者IL-6、IL-10、IFN-α、IFN-γ、TNF-α和TNF-β水平分别显著高于住院天数< 7 d者和生存者,差异均有统计学意义(P均< 0.001)。Logistic回归分析显示,高龄、阻塞性肺疾病全球倡议(GOLD)分级(3/4)、革兰阴性菌感染和高水平IL-6均为患者短期临床转归的重要影响因素(P = 0.01、0.01、0.04、0.03);而高龄、GOLD分级(3/4)、吸烟史、住院天数≥ 7 d和第1秒用力呼气量(FEV1)(%预测值)则均为患者长期临床转归的重要影响因素(P均< 0.05)。

结论

COPD合并肺部感染以革兰阴性菌感染最多见,因病原菌种类不同,IL、IFN和TNF等细胞因子水平差异较大,其中IL-6对患者短期临床转归影响较为显著。

Objective

To investigate the distribution of pathogenic bacteria in patients with chronic obstructive pulmonary disease (COPD) complicated with pulmonary infection, and to analyze the effect of related serum cytokine levels on the clinical outcome of patients.

Methods

From February 2015 to February 2017, a total of 178 patients with COPD complicated with pulmonary infection were treated in Heji Hospital Affiliated to Changzhi Medical College. Virus identification was done by nine respiratory tract viruses fluorescent labeling PCR. The species of bacteria were identified by BD BACTEC? FX40 automatic bacterial identification instrument. Serum interleukin (IL-6 and IL-10), interferon (IFN-α and IFN-γ) and tumor necrosis factor (TNF-α and TNF-β) were detected by enzyme linked immunosorbent assay (ELISA); while the effect of the above indexes on the clinical outcome of COPD patients complicated with pulmonary infection were analyzed, respectively.

Results

Total of 178 patients with COPD were divided into virus infection group (36 cases, 20.22%) and bacterial infection group (142 cases) according to the detected pathogen. Among the 142 cases with bacterial infection, 47 (26.41%) patients were with Gram-positive bacteria infection and 95 (53.37%) with Gram-negative bacteria infection. The levels of serum IL-6, IL-10, IFN-α, IFN-γ, TNF-α and TNF-β in bacterial infection group were significantly higher than those of virus infection group, all with significant differences (all P < 0.001). The levels of IL-6, IL-10, IFN-α, IFN-γ, TNF-α and TNF-β of patients with hospitalization days ≥ 7 days and the died cases were significantly higher than those with hospitalization days < 7 days and the survivors, respectively, all with significant differences (all P < 0.001). The results of Logistic regression analysis showed that elderly, Global Initiative for chronic obstructive lung disease (GOLD) grade (3/4), Gram-negative bacterial infection and high level of IL-6 were all important factors affecting the short-term clinical outcome of patients (P = 0.01, 0.01, 0.04 and 0.03). And elderly, GOLD grade (3/4), smoking history, hospitalization days ≥ 7 d, forced expiratory volume in the first second (FEV1) (% predictive value) were important factors for the long-term clinical outcome of the patients (all P < 0.05).

Conclusions

Gram-negative bacteria infection is most common among patients with COPD complicated with pulmonary infection. COPD and complicated with pulmonary infection is the most common infection of Gram-negative bacteria. Due to the different kinds of pathogenic bacteria, the levels of cytokines such as IL, IFN and TNF vary greatly; among whom, IL-6 has a significant effect on the short-term clinical outcome of patients.

表1 178例COPD合并肺部感染者的病原菌分布
表2 各组患者血清细胞因子水平( ± s
表3 178例COPD合并肺部感染者短期临床转归和长期临床转归的血清细胞因子水平( ± s
表4 患者短期临床转归影响因素的Logistic回归分析
表5 患者长期临床转归影响因素的Logistic回归分析
[1]
黄晓梅, 贺云鹏, 许元文. 慢性阻塞性肺疾病-哮喘重叠综合征和COPD患者临床特征的差异性[J]. 实用医学杂志,2016,32(15):2491-2494.
[2]
Pouwels SD, Hesse L, Faiz A, et al. Susceptibility for cigarette smoke-induced DAMP release and DAMP-induced inflammation in COPD[J]. Am J Physiol Lung Cell Mol Physiol,2016,311(5):L881-L892.
[3]
张弘, 蔡柏蔷. 慢性阻塞性肺疾病急性加重临床研究进展[J]. 中国呼吸与危重监护杂志,2016,15(2):198-202.
[4]
张金彪, 胡海涛, 刘玉欣, 等. 改良NAP活性检测在慢性阻塞性肺疾病急性加重期诊治中的应用价值[J]. 山东医药,2016,56(12):65-67.
[5]
黄书明, 王永莉. COPD急性加重期与COPD合并社区获得性肺炎的对比分析[J].国际呼吸杂志,2017,37(21):1618-1622.
[6]
Sheikh K, Coxson HO, Parraga G. This is what COPD looks like[J]. Respirology,2016,21(2):224-236.
[7]
Corrao S, Brunori G, Lupo U, et al. Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities[J]. Eur Respir Rev,2017,26(145):11035-11042.
[8]
Çolak A, Yılmaz C, Toprak B, et al. Procalcitonin and CRP as biomarkers in discrimination of community-acquired pneumonia and exacerbation of COPD[J]. J Med Biochem,2017,36(2):122-126.
[9]
胡绘, 赵苏, 孔德勇, 等. 联合检测hs-CRP、PCT和BNP在COPD急性恶化期中的诊断价值[J]. 重庆医学,2015(35):5010-5012.
[10]
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol,2016,138(1):16-27.
[11]
葛均波, 徐永健主编. 内科学.第8版[M]. 人民卫生出版社,2013.
[12]
Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: Impact, measurement and mechanisms[J]. Respirology,2015,20(8):1160-1171.
[13]
高晶晶, 程意, 罗勇. COPD常见共患病及其流行病学特点和临床意义[J]. 国际呼吸杂志,2017,37(1):70-75.
[14]
Tripple JW, McCracken JL, Calhoun WJ. Biologic therapy in chronic obstructive pulmonary disease[J]. Immunol Allergy Clin North Am,2017,37(2):345-355.
[15]
刘慧. 慢性阻塞性肺疾病流行病学及危险因素的研究进展[D]. 南昌大学,2017.
[16]
肖甜, 陈晓英, 王娜, 等. 中国大城市社区慢性阻塞性肺部疾病患者药物使用现状研究[J]. 中华流行病学杂志,2017,38(2):142-146.
[17]
López-Campos JL, Tan W, Soriano JB. Global burden of COPD[J]. Respirology,2016,21(1):14-23.
[18]
Hare KM, Smith-Vaughan HC, Chang AB, et al. Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronicendobronchial infections[J]. Vaccine,2017,35(5):747-756.
[19]
刘欣艳, 拓西平. 细胞因子/炎症因子及其通路在COPD合并营养不良中的研究进展[J]. 临床和实验医学杂志,2017,16(14):1454-1457.
[20]
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol,2016,138(1):16-27.
[21]
潘丽娟, 毛毅敏, 孙瑜霞, 等. 慢性阻塞性肺疾病患者肺部感染程度与肺功能的相关性分析[J]. 中华医院感染学杂志,2017,27(14):3161-3164.
[22]
金敬顺. 影响急诊高龄肺部感染患者预后危险因素的Logstic回归分析[J]. 临床急诊杂志,2016,17(7):521-523.
[23]
刘道喜, 刘慧, 王晓明, 等. 慢阻肺患者肺部感染对呼吸功能与细胞因子表达的影响研究[J]. 中华医院感染学杂志,2017,27(5):1019-1022.
[24]
周敏, 余祖琳, 王美芳, 等. 慢性阻塞性肺疾病患者肺部感染的临床特征及病原菌分布[J]. 中华医院感染学杂志,2017, 27(14):3158-3160.
[25]
钟国泽. 不同病原体致COPD患者急性加重期血清炎症标志物改变及对患者临床转归的影响[J]. 中国微生态学杂志,2018,30(4):456-460.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 曾雪灵, 杨思园, 常宇飞, 赵红心, 王凌航. 176例人类免疫缺陷病毒合并肺部感染者呼吸道病原体特点与免疫学特征[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 142-148.
[3] 董大红, 周明虎, 李芝朋, 许正峰. 碳青霉烯类抗生素联合呼吸机治疗肺部感染的临床疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 793-796.
[4] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[5] 张燕, 杨跃青, 邱峥. IgG 联合血清细胞因子对肺结核并发慢性肺曲霉菌病的诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 809-812.
[6] 郑玉, 许振浪, 陈青青. 类鼻疽致肺部感染患者的治疗及药学监护分析一例[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 670-672.
[7] 蒋丽芳, 林冰. 桑菊清解汤联合左氧氟沙星治疗社区获得性肺炎的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 458-461.
[8] 傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[9] 徐嘉愉, 张复华, 牛国敏, 梁家宝, 潘焕玉, 麦秀蕖, 杨国雷, 徐嘉良, 黄佑勇. Th1/Th2细胞因子谱在恶性血液肿瘤患者化疗后中性粒细胞缺乏伴感染的应用价值[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 143-150.
[10] 阿卜杜萨拉木·图尔荪麦麦提, 吐尔洪江·吐逊, 温浩. 肝脏缺血-再灌注损伤与cGAS-STING信号通路[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 394-397.
[11] 杨智钧, 谷佳, 丁聿贤, 张正奎, 于如同. 脑胶质瘤患者血清炎性因子水平与病理分级及预后的相关性[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 238-242.
[12] 丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[13] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[14] 闫维, 张二明, 张克, 安欣华, 向平超. 北京市石景山区40岁及以上居民早期慢性阻塞性肺疾病异质性及影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 533-540.
[15] 何秀, 敖的, 杨郑, 林小华. 改良呼吸支持策略对慢性阻塞性肺疾病急性加重合并Ⅱ型呼吸衰竭患者的疗效[J/OL]. 中华卫生应急电子杂志, 2024, 10(03): 140-144.
阅读次数
全文


摘要